И А Щукин
Pirogov Russian National Research Medical University · 37 works · 1,195 citations · h-index 5
Top works
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
- Neuroprotective Therapy with Citicoline (Ceraxon) in Patients with Ischemic Stroke
- Post-stroke rehabilitation training with a brain-computer interface: a clinical and neuropsychological study
- COVID-19-Associated Stroke
- Chronic cerebrovascular disease: diagnosis and treatment questions
- Development of Medicines for Hemorrhage Stroke: The Use of Magnetic Resonance Tomography for Estimating the Effectiveness of Histochrome
- Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with ischemic stroke
- Results of 4 years of therapy with divozilimab in patients with relapsing multiple sclerosis
- Neurocytoprotection advances in reperfusion therapy
- Ofatumumab — a new drug for the treatment of multiple sclerosis
- L-lysine aescinate for back pain: a systematic review
- Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule
- The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis
- [Possibilities of medical correction of moderate cognitive impairment].
- CYTOPROTECTIVE AND NEUROTROPHIC THERAPY FOR CEREBRAL STROKE
- Neurological disorders in eosinophilic granulomatosis with polyangiitis (Churg—Strauss syndrome)
- COVID-19 related stroke
- Efficacy and safety of the drug Cellex for the treatment of patients with cognitive impairment with chronic cerebral ischemia — results of a multicenter randomized double-blind placebo-controlled clinical trial
- [An influence of histochrome on the dynamics of neurological disorders and MRT-picture in experimental hemorrhagic stroke].